First Eagle Investment Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-363,362
Closed -$2.54M 397
2022
Q3
$2.54M Buy
363,362
+95,858
+36% +$751K 0.01% 178
2022
Q2
$1.82M Buy
267,504
+86,782
+48% +$885K 0.01% 228
2022
Q1
$2.55M Buy
180,722
+96,422
+114% +$1.29M 0.01% 127
2021
Q4
$1.22M Buy
+84,300
New +$1.2M ﹤0.01% 123

Other funds holding BVS

First Eagle Investment Management's BVS Position: Q4 2022 in Review

First Eagle Investment Management sold out of Bioventus (BVS) in Q4 2022, closing a stake of 363,362 shares — an estimated $2.54M sold.

First Eagle Investment Management first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $2.55M in Q1 2022. 85 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • First Eagle Investment Management reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • First Eagle Investment Management sold 363,362 Bioventus shares in Q4 2022, an estimated $2.54M.
  • First Eagle Investment Management first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • First Eagle Investment Management's Bioventus position peaked at $2.55M in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on First Eagle Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.